Cystic fibrosis drug Orkambi 'approved for use among 6-11 year olds'

The pharmaceutical firm making cystic fibrosis drug Orkambi says it has received EU approval to treat children.

Cystic fibrosis drug Orkambi 'approved for use among 6-11 year olds'
Wed, 10 Jan, 2018 - 10:11

The pharmaceutical firm making cystic fibrosis drug Orkambi says it has received EU approval to treat children.

Manufacturer Vertex says it will now be suitable for use for those aged 6 to 11.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

Benefit image

Introductory offer. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €12/month. Ts&Cs apply.

CONNECT WITH US TODAY

Whatsapp logo

WHATSAPP

Newsletter logo

NEWSLETTERS

Notification logo

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

Six arrested following violence at protest at City West in Dublin Six arrested following violence at protest at City West in Dublin
Internet addiction in teenagers Irish teens more concerned about their social media use than most of their peers across Europe 
Man Buying Drugs On The Street Demand for addiction treatment rises by 35% as more people seek help, report shows
CourtsCystic FibrosisOrkambiHealth
<p>The Oireachtas health committee will hear that, while numbers surviving cancer in Ireland are rising, they are 'rising faster and further in other countries'. Stock picture</p>

Cancer patient's surgery 'was cancelled due to overcrowding'

READ NOW

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Latest

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited